Graded Dalbavancin Challenge in a Patient with Severe Vancomycin Hypersensitivity Reaction.

Graded Dalbavancin Challenge in a Patient with Severe Vancomycin Hypersensitivity Reaction.

Clin Infect Dis. 2019 Jul 12;:

Authors: Ishizuka KT, Tran TK, Ayars AG, Chau AS, Chan JD

Abstract
Cross-reactivity should be considered when treating patients with a previous hypersensitivity reaction within the same class of antibiotics that share similar chemical structures. This case report describes a patient with severe hypersensitivity reaction to vancomycin who successfully tolerated a dalbavancin graded challenge.

PMID: 31300814 [PubMed - as supplied by publisher]